Coronavirus Vaccine Trial In Bangladesh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine: Bharat Biotech seeks nod to conduct COVAXIN trials in Bangladesh
If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for mass use
Reuters | January 21, 2021 | Updated 13:16 IST
The vaccine, developed with the Indian Council of Medical Research, was given the green light for restricted use in India this month without any efficacy data from a late-stage trial
India s Bharat Biotech has applied to conduct trials in Bangladesh for its coronavirus vaccine recently approved for emergency use at home, a senior official at Bangladesh s main medical research body told Reuters. If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for mass use. ....

Vinod Kumar Paul , Abdul Mannan , Bangladesh Medical Research Council , Sinovac Biotech , Indian Council Of Medical Research , Bangladesh Health , International Centre For Diarrhoeal Disease Research , Serum Institute Of India , Oxford University , Bharat Biotech , Indian Council , Medical Research , Dhaka Based International Centre , Diarrhoeal Disease Research , Serum Institute , Health Secretary Abdul Mannan , Covid 19 Vaccine , Covid 19 Vaccine Bharat Biotech , Bharat Biotech Covaxin , Coronavirus Vaccine In Bangladesh , Coronavirus Vaccine Trial In Bangladesh , Serum Inst , வினோத் குமார் பால் , அப்துல் மன்னன் , பங்களாதேஷ் மருத்துவ ஆராய்ச்சி சபை , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி ,